Once-daily RELEXXII (methylphenidate hydrochloride extended-release tablets) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults up to the age of 65 years and pediatric patients 6 years of age and older.1

    Once-daily RELEXXII is widely available in a broad range of dosing options to best suit each patient's need: 18-mg, 27-mg, 36-mg, 45-mg, 54-mg, 63-mg, and 72-mg
    Osmodex Drug Delivery Technology is utilized to deliver RELEXXII at a controlled release rate throughout the day1,2
    Convenient, once-daily dosing. 30-tablet prescription may also reduce out-of-pocket costs when insurance plans impose quantity limits
    A widely available, branded treatment to reduce the potential for generic fills
    Eligible patients may have improved access to a lower cost with the RELEXXII® Savings Card
see how it works

Available in “In-Between” Strengths

Once-daily RELEXXII (methylphenidate hydrochloride extended-release tablets) offers a wide range of dosing options to more gradually increase or decrease RELEXXII, in 9-mg increments, supporting a more tailored approach to treatment.

Among the broad range of RELEXXII doses, two serve as “in-between” strengths (45-mg and 63-mg), specifically designed to support targeted titration to help achieve the lowest effective dose and to help mitigate the need for multiple daily pills.

Pay as Little as $15 per Month with the RELEXXII® Savings Card*

References: 1. RELEXXII (methylphenidate hydrochloride extended-release tablets) package insert. Vertical Pharmaceuticals, LLC; 2023. 2. Data on file, Osmotica Pharmaceuticals.

*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. For full terms and conditions, click here.

All individuals depicted are models used for illustrative purposes only.